BioSpace News Archive

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, will report fourth quarter and full year 2018 financial results before the Nasdaq Global Market open on Thursday, March 14, 2019.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of new product solutions for its Twist Human Core Exome Kit and Twist Custom Panels next-generation sequencing (NGS) target enrichment workflows, allowing customers to move from sample to sequencer in a single day.

Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today commemorates Rare Disease Day®, a day devoted to elevating public understanding of rare diseases and calling attention to the special challenges faced by patients and families

Company also provides update on upcoming presentation from a Phase 2 proof-of-concept study and Phase 3 pivotal trial status

New NCCN Guidelines for Patients: Squamous Cell Skin Cancer explains risk factors and treatment options for cancer type that impacts millions every year.

Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today that the Company’s board of directors accepted the resignation of director Jeff Park, effective Feb. 22, 2019

Alexandria GradLabs™, the company’s latest strategic proprietary offering, will provide post-seed-stage life science companies with fully equipped, highly flexible and move-in ready office/laboratory step-up space to enhance the growth of the thriving San Diego life science ecosystem

The US Navy Veterans Mesothelioma Advocate is passionate about seeing to it that a US Navy Veteran with mesothelioma receives the very best possible financial compensation for this rare form of cancer caused by asbestos exposure.

Author and Digital Anthropologist Rahaf Harfoush explains why our fanatical pursuit of productivity is hurting our creative performance.

Live conference call and webcast at 8:30 a.m. ET on Thursday, March 7, 2019 to report its fourth quarter and full year 2018 financial results and provide a corporate update.